کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
10964137 1102705 2014 4 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Human papillomavirus vaccine uptake among males 11-26 years in United States: Findings from the National Health and Nutrition Examination Survey, 2011-2012
ترجمه فارسی عنوان
جذب واکسن پاپیلومای انسانی در میان مردان 11 تا 26 سال در ایالات متحده: یافته های بررسی ملی بهداشت و تغذیه، 2011-2012
موضوعات مرتبط
علوم زیستی و بیوفناوری ایمنی شناسی و میکروب شناسی ایمونولوژی
چکیده انگلیسی
Anogenital human papillomavirus (HPV) infection is the leading sexually transmitted infection in the United States. In October 2011, the quadrivalent HPV vaccine (HPV4) was recommended for males in the U.S. We analyzed a subsample of 11-26 year old (N = 1012) males, from the National Health and Nutritional Examination Survey 2011-2012 dataset, to examine HPV vaccine uptake. The initiation rates in the 11-17 years and the 18-26 years age-groups were 10.7% (95% confidence interval (CI): 8.09-16.6%) and 5.5% (95%CI: 3.1-9.5%) respectively. The corresponding HPV vaccine completion rates were 39.3% (16.7-67.7%) for the 11-17 year old males and 59.1% (37.2-77.6) for the 18-26-year-old males. Despite a slight increase, HPV vaccine uptake remained low among males. These findings can help in HPV vaccination policy in the United States, with a focus on informational messages directed toward young males and their parents in order to increase uptake of HPV vaccine.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Vaccine - Volume 32, Issue 49, 20 November 2014, Pages 6655-6658
نویسندگان
, , , ,